SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : T/FIF Portfolio -- Ignore unavailable to you. Want to Upgrade?


To: scaram(o)uche who wrote (840)4/26/1999 9:57:00 AM
From: LLCF  Read Replies (1) | Respond to of 1073
 
Robby Stevens upgrades entire "KINK" portfolio!!!!! Not really, but there's this:

CEPH: Jay Silverman, Robby Stevens upgrades CEPH to "strong buy" from buy.
CORR: BancBoston Robby Stevens senior biotech analyst Micheal G. King, Jr. today upgraded COR Therapeutics from Buy to Strong Buy. "In our view, small cap biotechs like COR are poised for a rebound and are about to narrow the performance gap with their large cap brethren" said King.

Hey, someones noticed!

DAK